Allergan confirms work toward bimatoprost for scalp hair
By direct email correspondence this week with Dr. Bauman, an official Allergan representative confirms the rumor that Dr. Scott Whitcup (Allergan's Executive VP of R&D) mentioned during a recent Q2 earnings conference call that they (Allergan) are in the "very early stages of exploring different formulations of bimatoprost to stimulate hair growth on the scalp." The representative described that Allergan's "near-term focus in this area will be on idenfying the appropriate formulation, initiating preclinical studies required for the FDA and working toward a sNDA submission."
Allergan's eyelash growth drug, Latisse